Telehealth payments

Embedded Payments for Telehealth Platforms: PayFac-as-a-Service vs Referral Partnerships

A platform that serves clinics can refer them to a processor, resell processing, register as a payment facilitator, or run payments under its brand on someone else's registration. Prescription sales change the weight of each choice.

By VyaPayPublished 7 min read

A telehealth platform can refer clinics to a processor, resell processing as an agent, register as a payment facilitator, or use PayFac-as-a-Service to offer payments under its own brand on a provider's registration. Referral is the lightest option and gives the least control. Registering as a PayFac gives the greatest control, and if your clinics sell prescriptions, Visa's high-integrity risk rules make it the heaviest.

PayFac-as-a-Service is an arrangement in which a software platform offers card and bank payments to its customers under its own brand, and shares in the revenue, while a payments provider holds the payment facilitator registration and handles sub-merchant boarding and funding. The platform gets a PayFac's product experience without building or registering one.

Four ways a platform can handle payments

The models differ in who signs with the clinic, whether the platform touches the money, and what it carries if a clinic goes wrong.

ModelThe clinic's payment contract is withPlatform's role in the moneyWhat the platform carries
Referral partnershipThe processorNone; may earn referral income or residualsLittle beyond the introduction
Agent or resellerThe processor or its acquirerNone directly; earns residualsRegistration as an agent where the network requires it
Payment facilitatorThe platform, as the clinic's PayFacReceives and disburses fundsNetwork registration, underwriting, monitoring and liability for sponsored merchants
PayFac-as-a-ServiceThe provider, with boarding inside the platform's productPlatform fees taken at settlement through split depositsThe product and the clinic relationship; the contract sets how risk is shared

The right model depends less on how many clinics you have than on what they sell. A platform whose clinics bill only for visits is in a different position from one whose clinics ship medication, because the second group brings Visa's high-integrity risk rules with it, and those rules weigh more the closer the platform sits to the money.

Referral partnerships and agent programs

These keep the platform out of the flow of funds. The clinic applies to a processor, signs its own merchant agreement, and is underwritten and funded directly. The platform earns a referral fee or residuals on the volume it sends.

The cost is control. Payments happen beside your product rather than inside it, reconciliation depends on how well the processor's reporting fits your software, and approval decisions belong entirely to the processor. If a clinic is declined or its account is closed, you hear about it from the clinic.

Registration can still reach you. Visa §1.9.5.1 requires an acquirer with high-integrity risk merchants to register agents that solicit them, as high-risk agents. Our reading: a platform that actively signs up clinics selling prescriptions non-face-to-face for an acquirer should expect that acquirer to ask whether it needs registering. VyaPay runs an agent program with residuals for partners who want this model.

What registering as a PayFac involves when clinics sell prescriptions

More than a standard PayFac registration. Visa treats non-face-to-face pharmaceutical sales (MCCs 5122 and 5912) as high-integrity risk, and its rules for a PayFac in that position stack up:

  • Separate registration. Under §5.3.1.3, a PayFac considered high-integrity risk must be registered as a high-integrity risk PayFac even if it's already registered as a PayFac.
  • A senior officer's signature. Under §10.4.6.1, the agreement with each high-integrity risk sponsored merchant must be signed by a senior officer of the PayFac, and the PayFac must report new sponsored merchants of that kind and monthly activity for all of them.
  • Daily monitoring by the acquirer. Under §10.4.5.2, the acquirer tracks daily volume, average ticket, receipt counts and disputes against a baseline, reviews weekly and must hand Visa the underwriting package and monitoring records within 7 calendar days on request.
  • Direct contracting. Under §10.4.6.2, Visa may require the acquirer to contract directly with a sponsored merchant that generates excessive disputes or credits in 12 months, or that takes action to evade responsibility for complying with Visa's rules.

Assessments land on the acquirer. Under §12.3.1.1, an acquirer that fails the high-integrity risk PayFac registration requirements faces USD 25,000 per month per PayFac, rising to USD 100,000 per 30-day period after three violations in a calendar year. That gives an acquirer every reason to examine a telehealth platform's PayFac application closely, and in our reading a platform in this position should expect underwriting closer to a pharmacy's than to a software company's.

Two qualifiers matter. Visa's merchant registration requirement doesn't apply to MCC 5122 or 5912 merchants accredited by NABP or another regulatory body Visa recognizes. And Mastercard runs its own registration: according to acquirer notices, it is now called the Specialty Merchant Registration program, includes non-face-to-face pharmaceutical merchants, and took effect in the US on July 24, 2026 for most categories.

What PayFac-as-a-Service changes

It separates the product from the registration. Your clinics board inside your software, see your brand and get paid through your platform, while the provider holds the PayFac registration and does the boarding, funding and reporting. You keep the revenue share and the customer relationship without building a compliance function sized for the rules above.

Some work stays with you whichever provider you use:

  • Knowing what each clinic sells. That decides its MCC and whether it's high-integrity risk. Visa's manual has no telehealth code; the code follows what is sold.
  • Getting the descriptor right. Visa §1.5.1.12 wants the name the merchant primarily uses with customers. On a white-label platform that is the clinic's brand, unless patients know the platform's name instead.
  • Passing documents through. Licenses, pharmacy relationships and certification status come from the clinic, through your onboarding.

VyaPay's PayFac-as-a-Service is built this way: you offer payments under your own brand and share revenue without building a payment facilitator, and VyaFac handles sub-merchant boarding, funding and reporting. VyaPay runs its own processor and underwrites in-house, so each clinic you bring is reviewed by the team that makes the underwriting call.

Taking a platform fee: split deposits and the fee-splitting question

Split deposits divide each sale at settlement, so the clinic, the platform and any agent are each funded their share without monthly invoicing. VyaFac supports this. It is mechanically cleaner than billing clinics after the fact, and your fee isn't a receivable you have to chase.

The legal question is separate from the mechanics. When a platform's fee is a percentage of a clinic's revenue from patient care, state fee-splitting and corporate practice of medicine rules can come into it, and those rules vary by state. Set the fee structure with healthcare counsel first, then configure payments to match it. How those rules shape who should hold the merchant account in the first place is covered in MSO, friendly PC and the merchant of record. None of this is legal advice.

Questions to settle before you choose

  1. Do your clinics sell prescriptions, and who charges the patient for the medication: the clinic or a pharmacy?
  2. Do you want to be in the flow of funds, or only in the product?
  3. Does your revenue model depend on a share of each payment, or on a subscription fee?
  4. Who will answer disputes: the clinic, the platform or the provider?
  5. Who collects licenses, pharmacy details and certification status at onboarding?
  6. What happens to a clinic's payment account if it leaves your platform?

Whichever model you pick, each clinic will face the same underwriting questions; they're laid out in the telehealth merchant account application checklist. If you're building the platform and a clinic brand at the same time, the wider sequence of decisions is in starting a telehealth company. To compare models against your own clinic mix, talk to VyaPay.

Frequently asked questions

Is a telehealth platform the merchant of record for its clinics?

Not under referral, agent or PayFac-as-a-Service arrangements, where each clinic is the merchant. Under a PayFac model the clinic is a sponsored merchant of the platform. In every case, the patient is paying the clinic for its care.

Do I need to become a payment facilitator to take a cut of each payment?

No. Split deposits let a provider divide each sale between the clinic and the platform at settlement. Whether a percentage-based fee is allowed for your clinics is a state-law question for counsel.

What is a high-integrity risk PayFac?

Visa's category for a payment facilitator considered high-integrity risk. In our reading that includes a PayFac whose sponsored merchants sell prescriptions non-face-to-face. It needs that registration even if it's already registered as a PayFac.

Can a platform earn residuals by referring clinics?

Under a referral or agent arrangement, the processor can pay residuals on the volume you send, while each clinic signs its own merchant agreement. VyaPay has an agent program with residuals; ask us about terms for your platform.

Sources

Talk to the team that underwrites you

Tell us what you prescribe or sell, how you bill and who your pharmacy partners are. You'll be talking to the people who run VyaPay's processor and make its risk decisions.

or call 833-4-VYAPAY

Let’s meet up!

Tell us about your business and someone from our team will reach out.